Latest News



November 23, 2015 1

By Anne O’Brien of Remedy Health Media

452650991

I have been quite the content creator lately. My October wedding provided plenty of fodder for Facebook posts, reaching not just my friends, but friends of friends. I was providing entertainment that might otherwise have been provided by a commercial publisher, maybe by my company’s site HealthCentral.com, or maybe your brand’s content.

Free content creation has been a concern to publishers from the beginning of the internet. As marketers, we thought we would become our own publishers. At the turn of the century many thought advertising would become obsolete as brands could just use search to drive their target audience directly to their own content. But managing that content, keeping it current, making it relevant, engaging, and trusted has proven to be a bigger challenge than most marketers can manage with great success. The challenges in the pharma space are even more compounded.

Our counterparts in consumer goods have engaged resources that can make their products cultural icons, or part of the consumer landscape. Take Buick’s product placement deal with ABC’s Black-ish. The team at Dentsu Aegis’ The Story Lab was able to not just pull off a simple product placement, but to marry and fully integrate their client, Buick, into the storyline. In one episode the ad agency featured in the program is pitching the Buick account. Per Molly Peck, Buick Marketing Manager: “With any of these integrations, they allow us to be organically woven into a storyline. We get the benefit of being part of the program, so people are actually watching it as opposed to advertising where viewers often don't watch it.” What a brilliant way to capture key copy points and articulate your brand value. Can you see that happening for an Rx product?

We certainly have a “higher bar” when marketing prescription products; so how will we maximize efficiencies, reach the most appropriate audiences and encourage patients to discuss our products’ treatments with their doctors in 2016?

Continuing the heavy mix of television will prove to be less impactful as even the older audiences are skipping ads on their DVR, using Netflix, Apple TV, and other devices to have more control. Many of my friends in advertising (and maybe you, too) will record all their programming simply because ad skipping is a more efficient way to watch TV.

In digging through reports from Nielsen and stories in the advertising trades, ad avoidance is focused on digital ad blocking technology. Reported by PageFair and Adobe, ad block usage has increased by 48% in the past year with 45 million monthly active users in the US. It is rare to hear stats on TV ad skipping and even more difficult to demonstrate who is paying attention to ads. TV remains a powerhouse but with 65% of U.S. adults having smartphones, and 45% having tablets, viewer distraction continues to be a challenge to marketers. Additionally “live TV” viewing by adults 18+ is down to four and a half hours per day – with 18-34 year olds spending 54% of their “media” time with TV.

Partnering or sponsoring the development of storylines about a condition relevant to your brand can be done on TV or in movies, but not without challenges (and good contacts like the team at The Story Lab have!). These tactics are fabulous opportunities for brands, but they don’t have the “legs” to sustain reach and awareness over time. Your advertising needs to be the thread that links the programming, requiring that the advertising message must do some heavy lifting. Beyond the legal requirements, DTC ads must be as engaging as the content surrounding them to ensure that they do not get skipped.

I have always been a firm believer in the catch phrase “content is king”. Is your creative strong enough to be king? Is it in an environment that complements the creative? Does it feel connected to the content… do they go hand and hand?

When I left Johnson & Johnson in 2007, I believed the real patients writing from HealthCentral.com had the most powerful stories to help others like themselves receive the best care possible and do all they can for their condition. I was confident those stories would also result in more visitor engagement with advertising. Today, Remedy Health Media’s team of producers and video experts are bringing powerful stories to life via short-form multimedia executions like Gay’s Rheumatoid Arthritis Live Bold, Live Now: Turning Points story. These stories are proven to have strong content and ad engagement. Results of a site survey found that:

  • 94% of respondents would recommend the story to others
  • 91% of respondents were inspired
  • 82% of respondents related to the story
  • 75% of respondents learned something new about the disease

The impact on the advertising is even more profound:

  • Respondents were 2x more likely to research the advertised medication online
  • Respondents were 2x more likely to talk to their doctor about the advertised medication
  • Respondents were 3x more likely to request a prescription for the advertised medication
  • Brand recognition of the advertised medication was 3x higher among Turning Points visitors

My 2016 prediction is there will be far more ad skipping, blocking, and avoiding, except where consumers are highly engaged in content that is sought out and relevant for their specific needs. If you need to relax and have a laugh and are also in the market for an Enclave Crossover, Black-ish is the perfect environment to be receptive to Buick’s message. If you are diagnosed with Rheumatoid Arthritis, you may be interested in a TV series featuring a patient with RA, but more likely you will be connected and deeply engaged to learn how real people with RA manage the very real hassles that the condition presents in real life and how they overcame these obstacles.

Looking back, I made some big life changes in 2007, not only did the career move prove to be advantageous; the online dating plan did, too. I am very happy to report that, after 8 years, I sealed the deal with my favorite ad skipper!

Anne OBrien


November 19, 2015 0

Stop the coughing before it becomes a social media plague.

By Peter Friedman of LiveWorld

Friedman-Nov2015-artworkIt’s taken a while, but the pharmaceutical industry has slowly realized the value of social media to reach caregivers, health care professionals, and patients to raise awareness and even track adverse events. According to the IMS Institute for Healthcare Informatics, only half of the 50 largest pharmaceutical companies worldwide use social media, and only 10 are on the Big Three: Facebook, Twitter, and YouTube.[1]

But patients, caregivers, and healthcare professionals are, and they’re posting about everything from what they need to, questions and adverse events. Placeholder pages aren’t going to cut it in this world where those affected are quick to complain and slow to retract. For pharmaceutical companies, that means taking cautious steps when social media becomes a petri dish for a full-blown PR crisis. As a regulated industry, pharmaceuticals especially need to be prepared for a possible social media crisis. Here are a few precautions pharmaceuticals should take.

  1. Re-evaluate – or even stop – scheduled posts.

Schedules are great when everything is going smoothly. But during a crisis, what may seem perfectly innocuous in any other context could further ruffle feathers. In crisis management mode, stopping all scheduled posts, on every channel, can help you refocus the message, as can pulling the plug on paid social promotions. This is the time to make sure your message is being seen, undiluted.

Only after you’ve got a handle on the crisis can you resume social media scheduling, but you’ll want to make sure anything being posted is unlikely to throw gas on smoking embers (and when dealing with humans, they are easily reignited). And certainly watch any new posts until you’re completely sure the crisis is over, even involving the legal team as necessary to ensure new posts don’t create additional liability.

  1. Take a time-out.

While a time-out won’t work in the OR, it can work wonders in the midst of a crisis. When you need to buy some time to work on the company’s response, use a “pause post.” Basically, the pause post will be tailored to the situation and the person and make it clear that you hear and acknowledge the issue, you’re working on a response, and you’ll have an update at [insert date and time here] on [your site].

While this can be difficult if discontent has spread virally over social media, it’s still worth it – just don’t post the same response to everyone.

  1. Pick your battles – and your battlefield.

Sometimes, just one person is stirring the pot, and there’s a way to nip it in the bud: get that person on the phone, preferably employing the most compassionate person you have on staff (if the person who calls the irate party is rude and argumentative, the situation will deteriorate very quickly). Listen to that angry person; just simply ask what happened. Take notes, recap your understanding to that person, and then make sure you’re following through. Address the issue and provide the person with a resolution, not just an apology.

But if the problem has spread, you’ll have to herd the cats, so to speak, and get everyone on the same platform to open up a dialogue. The company blog is an ideal place to get everyone off social media and into a single spot. It’s easy to share with a link and allows for a longer response.

  1. Write a well-thought out response.

In pharmaceuticals, there’s no easy way to respond to a crisis. But as with other brands, there are ways to successfully respond and diffuse a bad situation.

First, answer the question head-on and own the problem. Acknowledge that there’s a problem; avoid “we’re sorry you feel that way” at all costs. Then, unless there is a critical factual error, don’t start explaining. Just acknowledge, take responsibility, and apologize. Acknowledge the experience, and keep the brand human – convey humility in your response, and make sure it reads like a human wrote it. Get the resident Devil’s advocate on your team to read the response and ask for the snarkiest reply possible – that may transform the message altogether.

And this can’t be said enough: make sure you run the response through legal, indicating that this is a rush job, to avoid any liability in the future.

  1. Stay on the ball – don’t drop it.

Managing the crisis doesn’t stop at posting a response. It’s important to follow up, monitoring social media channels and answering questions as they arise – and they will arise. Make sure that the link to the central discussion is easily accessible as well.

In pharma, it’s also very likely that the media will jump on a crisis, and the PR and legal teams will be key in ensuring the right message gets to the press. Keep track of industry articles, bloggers, and more, and make sure that if an outlet publishes incorrect coverage, someone is able to reach out to provide correct information. As bloggers post, reach out directly to them to thank them.

Ultimately, the most important thing is to let the public know that the company is learning from the experience. It will turn the crisis from “evil pharmaceutical company” to “compassionate pharmaceutical company” much faster.

Reference:

[1] http://www.fiercepharmamarketing.com/special-reports/top-10-pharma-companies-social-media

 

About the Author

We hope you enjoyed this adapted excerpt from The CMO’s Social Media Handbook: A Step-by-Step Guide for Leading Marketing Teams in the Social Media World, by Peter Friedman, CEO and Chairman of LiveWorld. To read more, download a free PDF version, or buy the hardback or ebook via online booksellers. Connect with him @PeterFriedman.

 

Peter Friedman


October 28, 2015 0

Spend enough time with children and you will learn the difference between hearing and listening. You can tell kids to clean up until you are blue in the face without even a turn of their head, but whisper ice cream and they come running. This is the difference between reaching your audience and connecting with them.

With children it is easy to tell which messages are connecting. If the room is still a disaster, your message did not connect; when there is a line in front of you for ice cream, this is a sign you got their attention.

Talbot-Oct2015-ArtworkGetting the consumers’ attention is not all that different than children. People react to what is of interest to them, in psychology the term for this is salience.[i] As suggested by Max Sutherland & Alice K. Sylvester in Advertising and the Mind of the Consumer, one way advertisers can gain prominence in the minds of consumers is through repetition. The issue here is there is a difference between reach and frequency, and salience.

The key to connecting with your audience is about identifying the insights that make people feel as if you are speaking directly to them. To this point, veteran marketer Graciela Eleta says, “Great insights are not about adding more factual data or reasons for buying your brand. Finding a great insight is like having an ‘aha’ moment; it’s about unearthing a belief that unlocks consumer’s hearts & minds; one that says ‘this brand understands me and my life’.”

While making a connection is critical for all brands and all consumers, it is even more pronounced when reaching out to multicultural audiences. It is for this reason that Lisa Valtierra, an awarding winning pharmaceutical marketer says, “With a multicultural audience, whether you are talking about the Hispanic, African American, or LGBT segments, it is obvious when they are part of your plan from the start or just an afterthought.” This is why she ensures all creative begins with insights relevant to her target audience as opposed to adapting something from the general market.

It is the presence of consumer insights that explains why two brands with similar executions can perform differently. Unlike with children and ice cream, assessing the creative connect with consumers can be more challenging. This is because a rich marketing mix makes it hard to know which message is working or not.

Creative testing is a standard means of assessment. However, it is based on self-reported feedback of participants. With self-reporting there is potential for participants to give socially acceptable responses. Also referred to as the Hawthorne Effect, this is when people modify or improve an aspect of their response as a result of being observed.[ii]

If only we could understand what the consumers were thinking and not just telling us, it would be a game changer. The good news is that we can to some degree. Hans Berger, a German psychiatrist, was the first to record brain waves in the 1920s, having invented the electroencephalogram (EEG). Today, market researchers are incorporating the use of biometric monitoring tools, such as the EEG and eye tracking, in their studies to understand the unspoken responses of consumers.

Working together Nielsen and Univision, SMG Multicultural set out to try and understand Millennials. The work focused on the bi-lingual Millennials reaction to language and the cultural context of messaging. Using a combination of EEG and eye tracking, the study was able to determine that not only the language but the context in which it is delivered impacts message receptivity and drives greater emotional engagement and memory activation.

The problem with using tools such as EEGs has been cost, but this is changing. Cerora, a new company from Bethlehem, PA, is about to make brain monitoring more accessible. Developed to help with early detection of concussions, the Cerora Borealis multimodal biosensor solution is a single lead EEG brainwave sensor that wirelessly transmits data to a tablet or laptop. What this means is with a specialized headband collecting brainwaves and sending results to a tablet, market researchers now have an easy to use and affordable means of understanding what consumers are thinking.

Just because a piece of creative works with one audience does not mean it will work with another. As Lisa Valtierra has identified, the key to success starts with understanding to whom you are speaking. Be focused on who your audience is, what you want to tell them, and how you want them to feel. Keeping these principals in mind and leveraging the tools available today to understand consumers, you will be on your way to making a creative connection.

 

References:

[i] Max Sutherland & Alice K. Sylvester: Advertising and the Mind of the Consumer.

[ii] McCarney R, Warner J, Iliffe S, van Haselen R, Griffin M, Fisher P; Warner; Iliffe; Van Haselen; Griffin; Fisher (2007).

Eric Talbot


October 28, 2015 5

Molloy-Oct2015-ArtworkEditor’s Note: DTC Perspectives asked a leading creative expert to review current DTC ads for our Creative Assessment issue of DTC in Focus. OPDIVO and BELSOMRA were her standouts. Read what Brenda Molloy has to say about why these ads made her take special notice.

It’s necessary now more than ever for commercials to stand out from the crowd. The ability to cherry-pick what we watch, to fast-forward through commercials, and sometimes to not be exposed to paid media at all, means that if we want our clients to invest their marketing dollars in TV, they’re going to need a good story to tell. And it’s got to be different.

OPDIVO’s Longer Life

I was stopped in my tracks when I first saw this commercial. I watched silently, quickly hit the rewind button, and watched it again. And then I emailed a colleague who I knew was still up to see if they had seen it, too. We ended up sharing a banter of emails about how “groundbreaking” it was and how exciting it was to see a spot like this – not to mention the emotional pull it had, and admittedly, some tears shed.

Getting excited over pharma spots doesn’t often happen, but this time it was different. The OPDIVO commercial stands out, mostly because of what it is about: advanced squamous, non-small cell lung cancer. A cancer with not a great survival rate; this is the first time in years that there are advancements in this type of cancer. And, they are claiming, you have a chance to live longer because of it! That’s damn exciting to me.

In a category like lung cancer, you need to come across as authentic, and that’s what this spot is. It opens with dramatic music, panning over a cityscape as the sun rises. Cliché? Yes, but it works; this is huge after all. As the VO announces the big news for patients living with this type of lung cancer, copy is projected on buildings and integrated into the environment. It’s done very effectively and adds to the drama as the story unfolds with multiple people (stopped in their tracks, too) staring up at the words with their loved ones. They also did a nice job of integrating the OPDIVO icon (an exclamation point) into the environment for the latter part of the spot. Subtle, but showing the excitement and the big news. I wasn’t even bothered by the almost 40-second fair balance, because I was so drawn to seeing them with hope and life left to live. And perhaps one of the most compelling parts of this commercial is in the last six seconds. It’s where BMS thanks the doctors and patients who participated in the clinical trial. Now that’s pretty groundbreaking, too.

 

BELSOMRA’s Cats and Dogs

In a category that has been around for a while, do we really need another sleep aid? Luckily BELSOMRA has a different story to tell. It works differently than the other sleep aids by turning down Wake mechanisms in the brain, so Sleep can happen. But it’s going to have to look different too.

The concept of personifying Wake and Sleep with a dog and a cat is brilliant, and the Brief must have been spot on. The visual storytelling is engaging, as you see the woman having her Sleep in the beginning (represented by a white cat), but then Sleep disappears. She searches for Sleep, only to find it being disturbed by Wake, the dog. I love the interaction between them all and how she ultimately puts Wake into the little BELSOMRA bed on the floor while Sleep gets to hop into the woman’s bed. The animation of the two “animals” is superb. The movements of both creatures really take on the characteristics of a cat and a dog as they prance, pace, and walk throughout the commercial. Sleep looks more vulnerable and cute, and Wake looks a bit more rambunctious. He is, after all, keeping the woman up at night.

The fair balance is pretty heavy, so it’s good being distracted by the “animals” while the woman goes about her day with Wake interacting with her a little more (doing what dogs do), while Sleep lays a bit low in the background (like cats do). The film quality is absolutely gorgeous. The beautiful musical score throughout the spot sounds like a whimsical rendition of Smetana’s Die Moldau that keeps me humming it long after the commercial is over.

The commercial comes to a close like a nice fairytale where everyone is where they need to be. And, while this spot seems pretty polarizing when we talk about it around the water cooler, I think we can all agree that it has the stopping power to stand apart from the competition.

Brenda Molloy


October 28, 2015 1

“Creativity is thinking up new things. Innovation is doing new things.” – Theodore Levitt, author of Innovation in Marketing

Creative assessment in pharma is the ability to generate and evaluate new, varied, and unique ideas to achieve innovative approaches. Flexibility, originality, fluency, elaboration, and brainstorming are only a few of the factors connected to this tool. It involves finding new ways, making unusual associations, and seeing unexpected solutions. This technique uncovers difficulties, issues, gaps in information, and missing elements followed by formulating hypotheses about characteristics, evaluating, and testing guesses, and then, finally, communicating results. By applying the Innovation Styles Model to pharma, novel methods stimulate curiosity and promote divergences that bring about successful outcomes.

Innovation Styles Model

Visioning, Modifying, Exploring and Experimenting are four distinctive strategies included in the Innovation Styles Model that reveal how to approach new methods, ideas or products in pharma.

  1. DiPersio-Oct2015-Artwork1Visioning forms a mental image of the ideal future. Specifically, original ideas about the future are developed through intuition trailed by facts that are gathered to support those concepts. The long-term outcome is a clear future impression. Visioning endorses innovation by crafting the big picture and presenting certain direction over a length of time. This strategy encourages commitment and provides an impetus for an expansive vision.
  1. Modifying refines and optimizes what occurred previously. Priorities for improvement are established through facts and then intuition allows the entire picture to surface. A specific short-term goal is optimized and achieved. Modifying upholds innovation by adding to what predecessors have accomplished without developing anything new. This strategy also motivates a group to concentrate on realistic, short-term success.
  1. Exploring discovers new and interesting possibilities. Assumptions are questioned with intuition and new options are discovered. Hypotheses and insights are supported by ascertained facts. Exploring searches for unusual breakthroughs and challenges to uncover sole perspectives. This strategy is enthusiastic and hopeful under vague conditions.
  1. Experimenting combines and tests many exclusive groupings. Leverage points are identified with facts and then meaning is realized using intuition. New combinations expose strengths and weaknesses. Experimenting detects ways to overcome barriers, assimilates the ideas of many people, and generates new notions to makes decisions. This strategy tests and formulates new concepts in a detailed manner and provides organized methods to take risks in increments.

Practical Applications of Creative Assessment in Pharma

DiPersio-Oct2015-Artwork2

Strategic Planning

IDiPersio-Oct2015-Artwork3mproving core competencies, emphasizing cost control, focusing on comparative effectiveness, and elevating market access are part of a new strategic planning process. Payers, such as private insurance plans, pharmacy benefits managers, governments, and employers, have moved to the forefront of the pharma industry. They now strongly desire information about drug safety and efficacy to compare drug cost effectiveness to alternative treatments. In the past, determining how much payers would pay for drugs was a major challenge for marketers. However, most recently economically justifying and identifying the intrinsic value of a certain drug is a more important challenge.

R&D and New Products

DiPersio-Oct2015-Artwork4Creative ways are now engaged to capture treatment benefit through subjective research. These practices demonstrate full product value to patients, regulators, and payers. Patients visually express disease experience with mood boards using a collage of images and/or text that represents their emotions and thoughts with drawings or online platforms such as Pinterest. People receiving medical care also utilize body mapping to indicate the location on their body where they experience signs of disease and pain. Patients tell their story in video diaries, often times using smart phones to point out their disease experience in real time. In prior years, face-to-face interviews and focus groups were sufficient, and drug developers relied on merely clinical outcomes. Nevertheless, currently patients recognize the significance of comprehending and collecting subjective research about patient attitudes, preferences, and experiences.

Work Process Improvement

DiPersio-Oct2015-Artwork5Six Sigma and Lean Manufacturing allow pharma to predict and eradicate errors which boost operational efficiency and increase the chance of quality products and compliance, as opposed to relying on end-process testing. These techniques also optimize resources, control inventory, reduce waste and errors, improve customer service and change the market entirely. They identify and remove the causes of defects while minimizing variability in manufacturing and business methods. These tools employ empirical, statistical methods so that a certain group of people materialize as experts in these methods and become an integral part of the infrastructure of the organization. Presently, profits are declining due to greater competition emanating from generic brands and an increase in errors within the manufacturing process. On the other hand, Six Sigma and Lean Manufacturing offer the possibility of saving pharma an estimated $90 billion dollars internationally.

In conclusion, creativity develops fresh ideas, methods or products while innovation puts them into action. Combining creativity and innovation builds an assessment technique that effects positive and profitable change when the Innovation Styles Model is applied to the pharma industry. The practical application of the four unique strategies of the model (Visioning, Modifying, Exploring, and Experimenting) to the strategic planning process, R&D and new products, and work process improvement creates a departure that broadens the reach of pharma and acts as a trajectory to advance the industry worldwide.

 

References:

  • “How Does Creative Thought Differ from Critical Thought? Macquarie University. (2008)
  • McClearn, C. and Croisier, T. “Big Pharma’s Market Access Mission.” Deloitte University Press. (2013)
  • Meysner, S., Kitchen, H. and Humphrey, L. “Why Creative Research Methods are Essential in Pharmaceutical Outcomes Research.” Abacus International. Decision Resource Group. (2013)
  • “Six Sigma and Its Use in Pharmaceuticals.” Six Sigma Online. Aveta Business Institute. (2014)
  • “Understanding and Applying Innovation Styles(R) for Insight, Versatility and Impact.” Global Creativity Corp. (2007)

admin


September 24, 2015 0

We are creatures of habit. We buy the same products and follow the same daily routine. Unless compelling information is served to us the moment we’re making a decision, we are reluctant to change.

As the saying goes, old habits die hard.

For healthcare marketers, changing behavior within our industry can seem impossible. Earlier this year in DTC in Focus, I discussed the difficulty in implementing innovation within healthcare marketing. Changing patient behavior can be even harder.

Years ago, we sat on the exam table surrounded by outdated collateral and posters that seemed more decorative than anything else. A clutter of pamphlets about influenza or the dangers of smoking meant nothing if you were visiting the doctor for migraines. These were the early years of point-of-care marketing. With only mass delivery of paper collateral in their toolbox, healthcare marketers lacked the technology and focus to truly target campaigns. The lack of targeted delivery meant that the information being served was actually, by design, misinformation.

Doctor Discussing Records With Senior Female Patient

But the landscape has changed. For the past decade marketers have applied digital innovations to target consumers at high-impact moments. Digital point-of-care marketing makes it possible to address patients with relevant information at a time when their treatment is top of mind. When patients are sitting in the doctor’s office thinking about their condition right before speaking with their doctor the messaging that surrounds them is very powerful. Starting with the waiting room and following the journey through the appointment into the exam room, point-of-care messaging has become an increasingly necessary part of patient education.

As DTC marketers, it is becoming increasingly more important to ensure we target our exact patient. According to a study by ZS Associates, the majority of treatments are now targeted toward less than 1% of the US population. New point-of-care channels allow us to target specific patients – the ones that can benefit from these exact treatments. As a result, point-of-care spend is growing 8x faster than the overall DTC spend, totaling ~$400M in 2014. Point-of-Care marketing is no gamble, but a tried and true solution that consistently delivers ROI.

None of this is news, but it’s an exciting indicator of the road ahead.

While digital marketing is an incredible tool for DTC marketers, actually changing patient behavior the ultimate goal. Fortunately for us, innovation has progressed and we now have more tools to increase the frequency of engaging patients. New innovations like Mobile advertising capabilities are just the beginning of rounding out the patient journey. By taking a comprehensive approach to POC marketing and embracing the tools that are now at our disposal, we can actually achieve the impossible: change patient behavior.

At the same time, we as patients are increasingly incentivized to take advantage of these tools and be hyper-engaged in our treatment. With recent changes to the healthcare landscape, we are now responsible for more out-of-pocket healthcare costs. This means we want and need to know more about our conditions and the treatment options that are at our disposal. Read: we crave the information and consume it, especially when we’re at a doctor’s visit.

Similarly, healthcare providers are taking advantage of improvements in technology to redesign their workflow and create a more efficient practice with better care coordination. EMRs are rapidly improving in quality, which, when integrated with point-of-care messaging, can create a customized, contextual experience for every patient.

Medical tablet

Imagine walking into an office and receiving messaging on your mobile device that is relevant to the specific point in your treatment. Imagine being able to see, in the exam room, visualizations of your past visits, alongside your treatment options. As a patient, you will have more access to information that will better inform your decision-making.

So, remember those behaviors that were so hard to change? It is now easier than ever to understand the impact of changing them. Tech companies have made these technologies a reality, and they will continue to make it easier to guarantee returns for brands.

DTC marketers have built an industry creating hundreds of effective solutions to a singular challenge – how to change patient behavior – and we are at an inflection point. We have the opportunity to address the challenge with unprecedented accuracy, which means we need to approach these new channels intelligently and empathetically, always with the patient in mind. Our goal is to change patient behaviors for the better, and if we embrace and continue to innovate the platforms available, we will make that goal a reality.

There are millions of patients that need to change their behavior to live healthier. Let’s do something about it.

Ashik Desai


September 24, 2015 0

During his January 2015 State of the Union Address, President Barack Obama introduced the Precision Medicine Initiative as an effort that “will bring us closer to curing diseases like cancer and diabetes – and give all of us access to the personalized information we need to keep ourselves and our families healthier.” The question is how we will achieve this goal. The answer is through Point of Care (POC) ranging from POC testing to POC prescribing. Relying on prompt diffusion of innovation with this initiative will create maximum results and minimum waste in practicing health care.

Precision Medicine

DiPersio-Sept2015artwork1The National Research Council describes Precision Medicine (PM) as adapting medical treatment to the specific characteristics of each patient. It arranges individuals into subpopulations that differ in their likelihood to contract any particular disease. PM is the advanced and detailed understanding of the root causes of a disease and how best to respond with proper treatment taking into consideration genetic changes and ultimate cures.

POC Testing

The innovation of portable diagnostic and monitoring devices for POC testing depends on moving towards predictive, personalized, and preventive medicine while simultaneously moving forward with remedy medicine for existing diseases. POC testing allows pharmaceutical companies to develop more effective drugs geared to personalized needs. This synergy is influenced by the following factors:

  • Speed. Not only does testing produce instantaneous results, it also eliminates the need for laboratory bound samples requiring a wait time.
  • Portability. The size, portability, and battery power of POC testing devices allows them to be used in different environments including within the community or in a large hospital.
  • Convenience. Clinicians spend less time preparing paperwork for laboratory testing.
  • Reduced workload. Non-laboratory staff conducts testing instead of overworked trained clinicians whose time can be leveraged to achieve more medical advancements.
  • Connectivity. Errors are reduced by using USB and wireless connections not mandating manual transcription while central database input allows for data mining and research.
  • Sample quality. Time does not interfere with quality due to the lack of transport to the central laboratory.
  • Analytic viability. Integrity is maintained with analysis performed within a short time of sample being withdrawn.

POC Prescribing

DiPersio-Sept2015artwork2Preventive and therapeutic interventions, such as physicians dispensing prescription medications during medical visits, benefit patients without high cost or side effects. Health care professionals have the ability to prescribe the right drug for the right patient at the right time at the right place. Patient savings are realized in terms of time, energy, convenience, and money. Also, better health outcomes are achieved with patient adherence because the early stage obstacle of compliance is removed – the patient taking the time to process the prescription through mail order or at a pharmacy. Furthermore, assigning clinicians the power of POC prescribing confronts the dilemma of health disparities.

Diffusion of Innovation: Dynamics and Strategies for Success

Comprehending how to improve the pace of disseminating the concepts of this new Precision Medicine Initiative is of paramount importance to its success. Rapid diffusion of innovation is accomplished through the following guidelines and action plans.

  1. DiPersio-Sept2015artwork3Relative advantage. Gather an understanding of the ROI and cost mindset of the patient, medical staff, and decision makers.
  2. Trial ability. Engage ways to divide the process for tangible benefits.
  3. Observability. Choose viral marketing to uncover the invisible.
  4. Communication channels. Select mass media to inform and interpersonal methods to persuade while identifying the connectors and the correct target audience.
  5. Homophilous groups. Look for other homophilous groups outside of physicians, nurses, health strategic planners, and patient advocacy groups.
  6. Pace of innovation/reinvention. Situate listening standards for early warning about issues and monitor practices for potentially dangerous mishaps.
  7. Norms, roles, and social networks. Concentrate on target groups and expose chances to leverage existing social networks or create new ones.
  8. Opinion leaders. Identify opinion leaders and look for principals who have a broad range of information and a reputation for being most knowledgeable and respected.
  9. Compatibility. Become aligned with current behavior and values and mimic everyday universal functions.
  10. Infrastructure. Grasp current and future regulatory constraints.

In conclusion, the way to achieve the goal of the Precision Medicine Initiative recently launched by President Obama is utilizing two Point of Care methods which change the way medicine is practiced and health care is delivered. POC testing and POC prescribing promotes the health care climate shift toward prevention, early diagnosis, management of multiple chronic conditions, and eventual cure of existing diseases while increasing patient health engagement by encouraging patients to take a more active role in their health. Health care is more personalized through customization of interventions to individual patients based on the way information is processed. Specific transmittal dynamics accomplish the diffusion of innovation without delay and catapult the overall efficiency of medical practice.

 

References:

Berry, P. “Drug Dispensing at the Point of Care Benefits Patients.” Northwind Pharmaceuticals. (2015)
Cain, M. and Mittman, R. “Diffusion of Innovation in Health Care.” Institute for the Future and California HealthCare Foundation. (2002)
Moreno, C. “What Precision Medicine Is and How It Might Save Your Life Someday.” Reuters. (2015)
“Point of Care Diagnostic Testing.” National Institutes of Health. (2013)
Wickham, M., McComas, D. and Wickham, C. “Point of Care in Clinical Trials.” PharmaPhorum. (2010)

admin


September 24, 2015 0

In just the past handful of years, the Point of Care (POC) options available for messaging have undergone dramatic expansion. Where once POC meant patient messaging at the pharmacy or specialized magazines distributed to doctor office waiting rooms, we now have choices that offer an array of patient and healthcare provider (HCP) media solutions. New companies offer messaging services through in-office displays, Electronic Health Records (EHR), patient registration tablets, telemedicine, place-based apps, wearables and more.

479303426

With so many compelling choices to consider, the importance of creating a plan to execute, measure, and optimize programs delivered through these companies is critical. While goals may differ brand to brand, there are three strategies that can help you get the most from POC programs.

  1. Data driven insights are used to craft a complementary combination of relevant messages delivered to the right audience at the right place and time. For example, while messaging according to decile-based HCP target lists remains a staple consideration, it’s important to think about additional segmentation criteria made possible through the use of anonymous-patient data. The ability to select doctors according to their patients’ access to your brand, adherence, pattern of adoption, and more, allows us to consider a variety targeting criteria to help ensure campaign effectiveness.Staying with the HCP as our target example, a network of POC partners must be selected so that the combination of partners brings the desired reach across the targeted HCP offices. Such a network can be comprised of a single POC vendor type, like a group of in-office-display partners. Or it might make sense to knit together a variety of POC partners to include vendors that provide EHR messaging plus in-office display companies. The resulting plan can touch patients in the waiting room with a complementary message to the HCP through the EHR platform.
  1. True patient outcomes are used to understand what works best for each program and message type. Each POC media partner and message type represents a measurable tactic. It’s vital that the same data source and business rules are used for all measurement across a campaign so that each message and tactic can be evaluated in relation to the other. Staying with the example above, each patient response is aggregated to their targeted doctor and the relative impact of each POC media partner can be ranked. It’s important to employ anonymous patient data to ensure that a clear signal of behavior change is captured. Depending on the objective of the campaign, key performance indicators (KPIs) such as changes in new patient brand starts, adherence, or other metrics may be used to determine program effectiveness.
  1. Incremental results versus a control group need to be consistently monitored to optimize spend according to what’s working best. If new patient brand starts are the KPI of interest, then each new patient can be tied to the cost of acquisition through the POC tactic(s) that drove the outcome. POC media partners and tactics can be adjusted during the campaign in order to optimize spend where the tactics are having the greatest effect in driving new patient brand starts.

Of course, each campaign is different. Innovations in place-based messaging and other complimentary capabilities will continue to help POC programs bring new opportunities to drive HCP and patient behavior and improve overall outcomes.

These considerations represent an approach to optimization, and while there are other viable methods, media analytics are a fast evolving science. The explosion of available data in recent months makes it possible to apply cross channel targeting and optimization to all media channels (POC, digital, television, print) at the patient and HCP level. Today, we have more ways to assess our work and, most importantly, to use the findings to develop more effective messages and delivery channels that help HCPs, as well as improve direct-to-patient outcomes.

Two of Dave Nussbaum’s Publicis Health Media colleagues, Matt McNally & Sharon Patent, will delve further into this topic during their session on leveraging big data, only at the 2015 PEPP National Conference. Their discussion will teach you to know how, when, and where to engage with patients and HCPs. Don’t miss out – 2015 PEPP National Conference, held Nov 5-6 at the Ritz Carlton in Philadelphia. Register today!

 

Dave Nussbaum


August 15, 2015 0

Hispanics account for 1 out of every 5 adults who suffer from diabetes. Although it’s a major health concern for Hispanics (68% of Hispanics who have diabetes say they worry about someone in their family developing the disease vs. 52% of non-Hispanics), studies show that there is still a lack of education on the risks and management of this disease.

With this issue in mind, Univision Communications Inc. (UCI) wanted to find a way to better inform the Hispanic community about this disease, but it couldn’t be done alone. In an extraordinary moment of collaboration not often seen in the healthcare industry, Univision Farmacia, a service of UCI that offers discount prescription cards to Hispanics, partnered with Novo Nordisk, Montefiore, and seven leading healthcare organizations. These industry leaders, which included Inquisit Health, Nestle Health Science, The YMCA, Bayer Healthcare, The American Diabetes Association, CVS Health and Morris Heights Health Center, came together to create a patient program aimed at helping Hispanic diabetics live healthier lives.

Through a 360-degree promotional campaign across UCI’s properties, including digital, social, local TV and radio, the collaboration came to life in November of 2014 with a local community event at Hostos Community College in the Bronx. The event ended up falling on one of the rainiest and coldest days of the year, but spirits remained high among all who were helping to make it happen. Despite the weather, over 500 attendees showed up with one purpose, and that was to learn about diabetes, its symptoms, and treatment options.

ThinkstockPhotos-72919795-webThroughout the event, participants received health screenings, face-to-face counseling, panel discussions with experts, and more. In addition, we administered hemoglobin A1C tests to close to 300 attendees. Depending on the level of their hemoglobin A1C score, patients who signed up for the program were each placed into one of three groups and matched with the most appropriate treatment plan in accordance with their diabetes needs.

The first group was the pre-diabetics or those who were at risk for developing the disease (A1C score= 5.7-6.4%). These individuals were placed in The Diabetes Prevention Program, offered by Montefiore and the YMCA, and were provided with Nestle Boost Glucose Control products which they picked-up free of charge at CVS.

Next are the diabetics (A1C score= 6.5 and 8.9%). These patients were given almost the same treatment as the pre-diabetics, but they were also provided with a chronic condition management course at Montefiore Hospital and free glucose test meters provided by Bayer.

Lastly, our third group consisted of patients who had uncontrolled diabetes (A1C score=> 9). These individuals received the chronic condition management course at Montefiore Hospital, free meters and testing supplies from Bayer, nutritional products from Nestle, and they were assigned a peer mentor who provided healthy coaching advice in relation to their condition.

The three groups were monitored over a six month period, and then brought in for testing. Although we have yet to learn the results of this collaboration, which will be revealed in a white paper developed by Montefiore and Inquisit Health, what’s unique was the ability to bring together ten different organizations, each with the common goal of educating Hispanic diabetics and their families on how to make lasting changes that will help them live healthier lives.

Dennis O’Leary will delve further into this case study as he moderates a panel discussion, Novo Nordisk, Montefiore and UCI: Connecting the Hispanic Community with the Diabetes Care they Need, at the MCH National Conference. Discover how these companies worked together to find the common ground and help an underserved population manage this disease. Learn from Dennis, as well as the rest of our esteemed speaking faculty, at the 2015 MCH National Conference, held Oct 12-13 at The Westin in Fort Lauderdale. Register today!

Dennis OLeary


August 15, 2015 0

By 2050, the United States population will include almost 30% Hispanics/Latin-Americans, 13% African-Americans, and 9% Asian-Americans, with less than half of the population being Caucasian. Multicultural marketing is described as targeting and communicating to ethnic segments on their diverse cultural framework. Pain management is a universal dynamic among all cultures. The pharma marketing of pain medication to a culturally varied audience will be successful by understanding the Anderson Conceptual Framework and developing specific targeted strategies.

Anderson Conceptual Framework  

Predisposing Factors

DiPersio-Aug15Artwork2Health beliefs are predisposing characteristics that are not easily changed.

  • In the African-American culture, pain medications may be passed over due to the fear of addiction. Patient education should be incorporated into a strategy which not only teaches the facts about addiction but also allows individuals to accept medication while foregoing the use of folk healers, prayers, laying of hands and speaking in tongues.
  • In the Japanese-American culture, patients may believe that it is honorable to suffer silently through pain. A successful marketing strategy for this particular culture should include a clinical environment where the patient is comfortable expressing his feelings about drug acceptance while incorporating acupuncture, herbs and other natural remedies which are aligned with their culture.
  • In the Mexican-American culture, pain may be viewed as penance for sinful behavior or a poor life style while the machismo(a) attitude acknowledges they are courageous without medication. Once again, patient education should be part of the strategy to explain pain can be controlled with medication and also the negative impact when pain remains uncontrolled.

Enabling or Impeding Factors

Family support, access to medicine, and individual community are the enabling or impeding factors with pain medication supported by high, medium, and low degrees of ethnicity.

  • A high degree of ethnicity is found in patients who are first generation immigrants strongly affiliated with their culture, raised outside of the United States but now live in areas with a high ethnic concentration, not fluent in English and speak mostly their ethnic language in heavy accents.
  • A medium degree of ethnicity is found in patients who are second generation or acculturated first generation belonging to both worlds, have spent up to half of their lives in the United States but now live in areas with moderate ethnic concentration and are proficient in both their native language and English while speaking in light accents.
  • A low degree of ethnicity is found in patients who are second generation and onwards, less affiliated with their original culture, born and raised in the United States but now live in areas with low ethic concentration and bilingual but prefer speaking English in a neutral accent.

Perceived and Actual Need Factors

Pain medication is based on the perceived and actual necessity of drugs. Some cultures show a “nocebo” effect where individuals who do not believe in medication experience deteriorating symptoms due to pessimism about becoming healed. The opposite end of the spectrum is a placebo effect where medication is more beneficial if it is more intrusive. The Asian-American culture may view pain as a sign of weakness, believe that medication is inadequate without an injection and prefer an intravenous medication rather than highly effective analgesic tablets. The Mexican-American culture may view medication as unnecessary since they believe they are strong enough to endure the suffering naturally, and believe that a larger pill or bitter medicine are more effective than a smaller pill or medicine that has a pleasant taste. The African-American culture may perceive pain toleration without medication as heroic with past generations in slavery and reject medication entirely out of fear of a detrimental impact.

DiPersio-Aug15Artwork1Developing Specific Targeted Strategies

In a study conducted by Experian Simmons, almost 10 million Hispanics between the ages of 35 and 64 did not use a prescription drug during the past year with 61% spending up to 40 hours of their time each week watching Spanish language television, surfing the web, and visiting social media sites. In terms of context, behavior, and demographics, specific targeted digital and media marketing strategies will increase pharma revenue in pain medication by 50%. Also, strong brand affinity by a culturally diverse population encourages pharma to create direct relationships with target markets that are growing exponentially.

In conclusion, under the medical ethics tenet of beneficence, it is the duty of the physician to intervene with pain medication for the comfort and well-being of the patient with the goal of alleviating distress. Pain is applicable to all cultures. Different cultures create the formation of certain values and then these particular values create perceptions that motivate behaviors. Understanding the Anderson Conceptual Framework with unique cultural insights allows pharma to formulate successful specific targeted multicultural marketing strategies for pain medication.

References:

Alvarado, Anthony J. “Cultural Diversity: Pain Beliefs and Treatment among Mexican-Americans, African-Americans, Chinese-Americans and Japanese-Americans.” (2008). Senior Honors Theses. Paper 127.

McDonald. K.M., Sundaram, B., et al. “Closing the Quality Gap: A Critical Analysis of Quality Improvement Strategies.” Agency for Healthcare Research and Quality. (2007)

Guion, Lisa A. and  Kent, Heather. “Ethnic Marketing:  A Strategy for Marketing Programs to Diverse Audience.”  Allied Media Corp. Multicultural Communication. (2014)

Young Entrepreneur Council. “5 Tips to Refresh Your Multicultural Marketing Strategy.” Forbes. (2013)

Millerman, Steve. “Multiethnic Marketing:  The Billion Dollar Upside.”  PharmaExec. (2015)

admin